Perth-based burns treatment developer Clinical Cell Culture Ltd has closed its $10 million share purchase plan oversubscribed, as well as raising $3.8 million in a placement, to raise funds for further growth, the company announced today.
07/12/2006 - 15:45
C3 raises $13.8m for growth after SPP, placement
07/12/2006 - 15:45
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)